In lung adenocarcinoma, some studies have implicated MFN2 in exerting tumor‐promoting effects [8, 9], whereas tumor‐suppressing effects of MFN2 have also been reported [10, 11, 12]. This evidence concerns the gene MFN2 and lung adenocarcinoma.